Lim F J, Blyth C C, Keil A D, DE Klerk N, Moore H C
Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, The University of Western Australia,PO Box 855, West Perth, Western Australia, 6872,Australia.
PathWest Laboratory Medicine WA, Princess Margaret Hospital for Children,GPO Box D184, Perth, Western Australia, 6840,Australia.
Epidemiol Infect. 2017 Jun;145(8):1688-1698. doi: 10.1017/S0950268817000413. Epub 2017 Mar 2.
Changes in respiratory pathogen testing can affect disease burden estimates. Using linked data, we describe changes in respiratory virus testing among children born in Western Australia in 1996-2012. We extracted data on respiratory specimens from these children from birth to age 9 years. We estimated testing rates by age, year, Aboriginal status and geographical location. Predictors of testing among children hospitalised at least once before their 10th birthday were identified using logistic regression. We compared detection methods for respiratory viruses from nasal/nasopharyngeal (NP) specimens by age and year. Of 83 199 virology testing records in 2000-2012, 80% were nasal/NP specimens. Infants aged <1 month had the highest testing rates. Testing rates in all children increased over the study period with considerable yearly fluctuations. Among hospitalised children, premature children <32 weeks gestation had over three times the odds of being tested (95% CI 3·47-4·13) than those born at term. Testing using molecular methods increased from 5% to 87% over the study period. Proportion of positive samples increased from 36·3% to 44·4% (P < 0·01); this change was greatest in children aged 2-9 years. These findings will assist in interpreting results from future epidemiology studies assessing the pathogen-specific burden of disease.
呼吸道病原体检测的变化会影响疾病负担估计。利用关联数据,我们描述了1996 - 2012年在西澳大利亚出生儿童的呼吸道病毒检测变化情况。我们提取了这些儿童从出生到9岁的呼吸道标本数据。我们按年龄、年份、原住民身份和地理位置估算检测率。使用逻辑回归确定了在10岁生日前至少住院一次的儿童中检测的预测因素。我们按年龄和年份比较了鼻/鼻咽(NP)标本中呼吸道病毒的检测方法。在2000 - 2012年的83199条病毒学检测记录中,80%是鼻/NP标本。年龄小于1个月的婴儿检测率最高。在研究期间,所有儿童的检测率都有所上升,且每年有较大波动。在住院儿童中,孕周小于32周的早产儿接受检测的几率是足月儿的三倍多(95%CI 3·47 - 4·13)。在研究期间,使用分子方法进行检测的比例从5%增加到了87%。阳性样本比例从36·3%增加到了44·4%(P < 0·01);这种变化在2 - 9岁儿童中最为明显。这些发现将有助于解释未来评估病原体特异性疾病负担的流行病学研究结果。